In regulatory news:

The DEA on Friday proposed a 20 percent reduction in the manufacture of certain commonly prescribed opioid painkillers as well as other controlled substances for next year. The proposal comes as U.S. regulators and lawmakers take steps to limit the supply of opioids to combat the epidemic of abuse, overdose and addiction.

Read more via Reuters here.

Leave a Comment

Your email address will not be published. Required fields are marked *